Drug Interactions between letibotulinumtoxinA and Scot-Tussin DM
This report displays the potential drug interactions for the following 2 drugs:
- letibotulinumtoxinA
- Scot-Tussin DM (chlorpheniramine/dextromethorphan)
Interactions between your drugs
chlorpheniramine dextromethorphan
Applies to: Scot-Tussin DM (chlorpheniramine / dextromethorphan) and Scot-Tussin DM (chlorpheniramine / dextromethorphan)
Using chlorpheniramine together with dextromethorphan may increase side effects such as dizziness, drowsiness, confusion, and difficulty concentrating. Some people, especially the elderly, may also experience impairment in thinking, judgment, and motor coordination. You should avoid or limit the use of alcohol while being treated with these medications. Also avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medications affect you. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
chlorpheniramine letibotulinumtoxinA
Applies to: Scot-Tussin DM (chlorpheniramine / dextromethorphan) and letibotulinumtoxinA
Consumer information for this interaction is not currently available.
MONITOR: Use of anticholinergic drugs after administration of botulinum toxin may potentiate systemic anticholinergic effects such as dry mouth, blurred vision, and urinary disorders. Botulinum toxin inhibits the release of acetylcholine from peripheral cholinergic nerve endings, thus additive or synergistic anticholinergic effects may occur when these agents are used together.
MANAGEMENT: Patients should be advised that systemic anticholinergic side effects such as dry mouth, blurred vision, and urinary disorders may increase if agents with anticholinergic properties (e.g., sedating antihistamines; antispasmodics; neuroleptics; phenothiazines; skeletal muscle relaxants; tricyclic antidepressants; disopyramide) are used after administration of botulinum toxin.
References
- "Product Information. Myobloc (rimabotulinumtoxinB)." Elan Pharmaceuticals PROD
- "Product Information. Dysport (abobotulinumtoxinA)." Tercica Inc PROD
- "Product Information. Botox (onabotulinumtoxinA)." Allergan Inc PROD
- "Product Information. Xeomin (incobotulinumtoxinA)." Merz Pharmaceuticals (2022):
- "Product Information. Jeuveau (prabotulinumtoxinA)." Evolus, Inc. (2022):
- "Product Information. Daxxify (daxibotulinumtoxinA)." Revance Therapeutics, Inc. 1 (2022):
- "Product Information. Letybo (letibotulinumtoxinA)." CROMA Australia Pty Ltd 1 (2022):
- "Product Information. Letybo (letibotulinumtoxinA)." Hugel Aesthetics (2024):
Drug and food interactions
chlorpheniramine food
Applies to: Scot-Tussin DM (chlorpheniramine / dextromethorphan)
Alcohol can increase the nervous system side effects of chlorpheniramine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with chlorpheniramine. Do not use more than the recommended dose of chlorpheniramine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
dextromethorphan food
Applies to: Scot-Tussin DM (chlorpheniramine / dextromethorphan)
Alcohol can increase the nervous system side effects of dextromethorphan such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with dextromethorphan. Do not use more than the recommended dose of dextromethorphan, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.